Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
293T/17 |
Human embryonic kidney subclone 17, SV40 large T antigen inserted | ATCC CRL-11268 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | application note |  |
||
293T/17 |
Human embryonic kidney subclone 17, SV40 large T antigen inserted | ATCC CRL-11268 | Human | urinary system | unknown | adherent | plasmid | Metafectene | application note | |
|||
293T/17 |
Human embryonic kidney subclone 17, SV40 large T antigen inserted | ATCC CRL-11268 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | |
|||
293TN |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivat of 293T) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | F. Walter et al., Cell Death and Differentiation, 2015, 22: 1502-1516; doi:10.1038/cdd.2014.241 | Link | ||
293TN |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivat of 293T) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | F. Walter et al., Cell Death and Differentiation, 2015, 22: 1502-1516; doi:10.1038/cdd.2014.241 | Link | ||
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | C. Amantini et al., Oncotarget, 2016, 7(31): 50180-50194 | Link | |
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. Caprodossi et al., Carcinogenesis, May 2011; 32: 686 - 694 | Link | ||
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Mani et al., Maniet al. BMC Cancer, 2015, 15:224; DOI: 10.1186/s12885-015-1239-4 | Link | ||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | |||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | ||
AD293 |
Human embryonic kidney cell line (derivative of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | M. Dumitrescu et al., J. Vis. Exp., 2021, 172: e61691, doi:10.3791/61691 | Link | |||
AD293 |
Human embryonic kidney cell line (derivative of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | M. Dumitrescu et al., Int. J. Mol. Sci., 2020, 21, 6011, doi:10.3390/ijms21176011 | Link | |||
AD293 |
Human embryonic kidney cell line (derivat of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | S. Wohlfart et al., Clin. Genetics, 2019, 95: 427–432, DOI: 10.1111/cge.13503 | Link | ||
AD293 |
Human embryonic kidney cell line (derivat of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | S. Wohlfart et al., Am. J. Med. Genet. Part A, 2015, 170A: 249-253, DOI 10.1002/ajmg.a.37412 | |||
AD293 |
Human embryonic kidney cell line (derivat of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | virusproduction | K2 Transfection System | application note | |
|||
Caki-1 |
Human kidney clear cell carcinoma cell line | ATCC HTB-46 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | T. Liu et al., Mol. Cancer Ther., May 2009; 8: 1227 - 1238 | Link | ||
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Pelisek et al., J Mol Med (Berl), Nov 2002; 80(11): 724-36 | |||
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | |
|||
EJ138 |
Human bladder carcinoma cell line | ECACC 85061108 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
Flp-In 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. K. Shrestha et al., J. Biol. Chem., 2019,doi/10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Birk et al., J. Cell Sci., Apr 2013; 126: 1604 - 1617 | Link |
 |
Fax-Bestellung |
Geben Sie Ihre Bestellung einfach und bequem per Fax auf unter folgender Nummer:
0049 89 32479952
Europa
0049 89 32479952
USA/Kanada
01149 89 32479952
Australien
001149 89 32479952
 |
Email-Bestellung |
Geben Sie Ihre Bestellung einfach und bequem per Email auf unter folgender Adresse: order@biontex.com
 |
Online-Bestellung |
Für die korrekte Darstellung der Preise und Versandkosten ist die Wahl Ihrer Region nötig.